| Brain MRI findings in patients in the intensive care unit with COVID-19 infection SG Kandemirli, L Dogan, ZT Sarikaya, S Kara, C Akinci, D Kaya, Y Kaya, ... Radiology 297 (1), E232-E235, 2020 | 325 | 2020 |
| Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series L Dogan, D Kaya, T Sarikaya, R Zengin, A Dincer, IO Akinci, N Afsar Brain, behavior, and immunity 87, 155-158, 2020 | 148 | 2020 |
| Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection HK Okur, K Yalcin, C Tastan, S Demir, B Yurtsever, GS Karakus, ... New microbes and new infections 37, 100756, 2020 | 48 | 2020 |
| Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report R Zengin, O Beyaz, ES Koc, IO Akinci, S Kocagoz, G Sagcan, E Ovali, ... Stem cell investigation 7, 2020 | 29 | 2020 |
| Adverse cardiac events related to hydroxychloroquine prophylaxis and treatment of COVID-19 R Zengin, ZT Sarıkaya, N Karadağ, Ç Çuhadaroğlu, Ö Ergönül, ... Infect Dis Clin Microbiol 1, 24-26, 2020 | 10 | 2020 |
| Sepsis biomarkers for early diagnosis of bacteremia in emergency department NY Uyar, AK Sayar, AS Kocagöz, MA Serdar, R Zengin, ZT Sarıkaya, ... The Journal of Infection in Developing Countries 17 (06), 832-839, 2023 | 1 | 2023 |
| Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients? L Dogan, A Allahverdiyeva, M Önel, S Meşe, E Saka Ersin, İ Anaklı, ... Journal of International Medical Research 50 (11), 03000605221137443, 2022 | 1 | 2022 |
| The effectiveness of ACB-IP 1.0 universal pathogen free concentrated cocktail convalescent plasma in COVID-19 infection C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydın, NO Sahin, ES Karagacli, ... medRxiv, 2021.03. 05.21251413, 2021 | 1 | 2021 |
| Human Metapneumovirus Infection in Adults as the Differential Diagnosis of COVID-19 M Enfeksiyonu Turk J Intensive Care 19, 90-93, 2021 | 1 | 2021 |
| Standart Protokol ile Tedavi Edilen COVID-19 Pnömonisi Hastaları: Beş Yoğun Bakım Ünitesinin Gözlemsel Sonuçları. HS Demirel Kaya, O Mammadov, L Doğan, ZT Sarıkaya, İK Özdemir, ... Turkish Journal of Intensive Care, 2020 | 1 | 2020 |
| Mesenchymal stromal cell therapy for critically ill patients With COVID-19 K Yalcin, C Hemsinlioglu, R Zengin, M Sonmezoglu, R Hakan, ... JMIR Prepr 20206, 2020 | 1 | 2020 |
| Can CMV reactivation be a biomarker of persistent inflammation, immunosuppression, and catabolism syndrome? L Dogan, R Zengin, S Kocagöz, IO Akinci Journal of Critical Care 81, 154742, 2024 | | 2024 |
| P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION K Yalcin, E Erdogan, R Zengin, T Ozcelik, NO Kurkcu, H Ozdogu, C Kis, ... HemaSphere 7 (S3), e6163977, 2023 | | 2023 |
| Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection. A Işiklar, R Zengin, V Balci, AS KOCAGÖZ, G BAŞARAN Turkish Journal of Oncology/Türk Onkoloji Dergisi 37 (4), 2022 | | 2022 |
| THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION (preprint) C Hemsinlioglu, NB Pelit, K Yalcin, OS Gunaydin, NO Sahin, ES Karagacli, ... | | 2021 |
